Home >> Performance >> Archive >> Naos fund reaps life science and biotech rewards

Naos fund reaps life science and biotech rewards

April 18, 2012  

Read more:




Investments in Australian biotech and life sciences companies helped lift the Naos Emerging Long Short Equity Fund in March. The fund, which focuses exclusively on Australian equities, rose 9.33% in March, after a 11.83% gain in February.

“We don’t...

TAKE A FREE TRIAL

The full contents of this article are available to active AsiaHedge subscribers and trialists only.

To continue reading please, take a free trial or subscribe to AsiaHedge.

Subscribe

Subscribers have unlimited access to all current content, including hedge fund performance Live League Tables. Start your subscription today - click on the button below.

Subscribe now



  1. Market wizards or masters of mirage? Noted authors Schwager, Lack and Drobny to discuss at Symposium
  2. MatlinPatterson markets munis
  3. Don't be surprised when helicopter Ben flies away
  4. Campbell offers access to non-trend-following strategy
  5. Michael Geismar’s $710,000 blackjack breakfast

Popular Searches on HFI